Fred R. Hirsch on Muck Rack

Fred R. Hirsch

Colorado, New York
As seen in: Cancer Investigation, Fortune, MDPI, JAMA Oncology, The Lancet, HemOnc Today, American Journal of Managed Care, ONCOLOGY journal, CURE Magazine, The ASCO Post and
I am Executive Director at the Center for Thoracic Oncology at Mount Sinai Hospital , NYC and Professor of Medicine at Icahn Medical School at Mount Sinai, NY
Is this you? As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work. Claim your profile

Get in touch with Fred R.

Contact Fred R., search articles and posts on X, monitor coverage, and track replies from one place.

Learn more about Muck Rack

Actions

Share this page

Is this you?

As a journalist, you can create a free Muck Rack account to customize your profile, list your contact preferences, and upload a portfolio of your best work.
Claim your profile

Articles

Choosing the Optimal NSCLC Treatment

|
By Fred R. Hirsch, Mary Beasley, Nicole Hall, Philip C. Mack, Daniel G Nicastri, Nicholas Rohs, Christian Rolfo
| ONCOLOGY journal Verified
A group of experts discuss the current treatment algorithm for NSCLC, as well as novel approaches under investigation, the impact of molecular biomarkers on their treatment decisions, and the importance of clinical trials. Stay up to date on recent advances in the multidisciplinary approach to cancer.
Open in Who Shared Issue with article?

Important NSCLC Biomarkers

|
By Fred R. Hirsch, Mary Beasley, Nicole Hall, Philip C. Mack, Daniel G Nicastri, Nicholas Rohs, Christian Rolfo
| ONCOLOGY journal Verified
Fred R. Hirsch, MD, PhD, leads a discussion with his Mount Sinai colleagues about important biomarkers found in non-small cell lung cancer, including those that provide predictive and prognostic information.
Open in Who Shared Issue with article?

Providing Supportive Care to Patients with NSCLC

|
By Fred R. Hirsch, Mary Beasley, Nicole Hall, Philip C. Mack, Daniel G Nicastri, Nicholas Rohs, Christian Rolfo
| ONCOLOGY journal Verified
Helping patients manage potential treatment-related adverse events is an essential part of the overall care plan in the treatment of non-small cell lung cancer. Experts provide strategies to address adverse events and best practices for providing the supportive care needed for patients.
Open in Who Shared Issue with article?
See all 37 licensed articles (94 Total)
 •  Privacy  •  Terms  •  Security and Legal  •   •   •   • 

© 2026 Muck Rack

SOC 2® Certified